Senseonics, Incorporated

Senseonics, Incorporated company information, Employees & Contact Information

Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

Company Details

Employees
147
Address
20451 Seneca Meadows Pkwy, Germantown,maryland 20876,united States
Phone
(301) 515-7260
Email
ad****@****ics.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Germantown, Maryland
Looking for a particular Senseonics, Incorporated employee's phone or email?

Senseonics, Incorporated Questions

News

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time - Yahoo Finance

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time Yahoo Finance

Senseonics (NYSE American: SENS) sets Nov 5 third quarter 2025 results release, call - Stock Titan

Senseonics (NYSE American: SENS) sets Nov 5 third quarter 2025 results release, call Stock Titan

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update - Yahoo Finance

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update Yahoo Finance

Senseonics Holdings, Inc. to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Nasdaq

Senseonics Holdings, Inc. to Announce Second Quarter 2025 Financial Results on August 6, 2025 Nasdaq

$8.1M Q3 2025 Revenue — Senseonics Sees 160% U.S. New Patient Growth; 1:20 Reverse Split Oct 17 - Stock Titan

$8.1M Q3 2025 Revenue — Senseonics Sees 160% U.S. New Patient Growth; 1:20 Reverse Split Oct 17 Stock Titan

Senseonics Holdings, Inc. Reports Second Quarter Financial Results - Yahoo Finance

Senseonics Holdings, Inc. Reports Second Quarter Financial Results Yahoo Finance

Year-Long CGM Pioneer Senseonics Takes Full Control of Eversense 365, Projects 70% Margins at Scale - Stock Titan

Year-Long CGM Pioneer Senseonics Takes Full Control of Eversense 365, Projects 70% Margins at Scale Stock Titan

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement - Yahoo Finance

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement Yahoo Finance

Senseonics Holdings, Inc. Reports First Quarter Financial Results - Yahoo Finance

Senseonics Holdings, Inc. Reports First Quarter Financial Results Yahoo Finance

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement - Yahoo Finance

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement Yahoo Finance

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes - Yahoo Finance

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes Yahoo Finance

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement - Yahoo Finance

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement Yahoo Finance

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference - Yahoo Finance

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference Yahoo Finance

Diabetes CGM Tech Leader Senseonics Sets Q2 2025 Earnings Date: Key Details for Investors - Stock Titan

Diabetes CGM Tech Leader Senseonics Sets Q2 2025 Earnings Date: Key Details for Investors Stock Titan

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting - Yahoo Finance

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting Yahoo Finance

Senseonics Unveils FDA-Approved 365-Day CGM System at ADA 2025 Analyst Event | SENS Stock News - Stock Titan

Senseonics Unveils FDA-Approved 365-Day CGM System at ADA 2025 Analyst Event | SENS Stock News Stock Titan

Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch - Yahoo Finance

Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch Yahoo Finance

Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results - Yahoo Finance

Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results Yahoo Finance

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire

Senseonics Secures $50M Funding Boost: Abbott Takes Strategic Stake in Diabetes CGM Innovation - Stock Titan

Senseonics Secures $50M Funding Boost: Abbott Takes Strategic Stake in Diabetes CGM Innovation Stock Titan

Senseonics Holdings, Inc. Reports Strong Q4 2024 Performance and Launch of Eversense 365 Continuous Glucose Monitoring System - Nasdaq

Senseonics Holdings, Inc. Reports Strong Q4 2024 Performance and Launch of Eversense 365 Continuous Glucose Monitoring System Nasdaq

Senseonics Secures $75M Financing Deal: Abbott Joins with $25M Strategic Investment for CGM Launch - Stock Titan

Senseonics Secures $75M Financing Deal: Abbott Joins with $25M Strategic Investment for CGM Launch Stock Titan

Sequel Med Tech and Senseonics Integrate Technologies to - GlobeNewswire

Sequel Med Tech and Senseonics Integrate Technologies to GlobeNewswire

Senseonics' Eversense CGM Doubles Patient Growth, Hits Record Shipments in Q4 2024 - Stock Titan

Senseonics' Eversense CGM Doubles Patient Growth, Hits Record Shipments in Q4 2024 Stock Titan

Senseonics Secures Massive $77.8M Funding Boost as Abbott Backs Next-Gen Diabetes Monitor Launch - Stock Titan

Senseonics Secures Massive $77.8M Funding Boost as Abbott Backs Next-Gen Diabetes Monitor Launch Stock Titan

Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity (NYSE:SENS) - Seeking Alpha

Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity (NYSE:SENS) Seeking Alpha

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM - Business Wire

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM Business Wire

PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care - Business Wire

PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care Business Wire

Breakthrough: World's First One-Year CGM Partners with Advanced Insulin Delivery System for Diabetes Care - Stock Titan

Breakthrough: World's First One-Year CGM Partners with Advanced Insulin Delivery System for Diabetes Care Stock Titan

IDT’s Customer Senseonics Receives FDA Approval for Its Implantable Glucose Sensor - Renesas Electronics

IDT’s Customer Senseonics Receives FDA Approval for Its Implantable Glucose Sensor Renesas Electronics

SENS - Senseonics Latest Stock News & Market Updates - Stock Titan

SENS - Senseonics Latest Stock News & Market Updates Stock Titan

FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring - MultiVu

FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring MultiVu

Implantable Glucose Sensor Featuring IDT Sensing Technology Awarded CE Mark - Renesas Electronics

Implantable Glucose Sensor Featuring IDT Sensing Technology Awarded CE Mark Renesas Electronics

Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems - Newswire.com

Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems Newswire.com

Roche Diabetes Care and Senseonics Announce Distribution Agreement for the Eversense® CGM System Introducing the First Implantable Long-term Glucose Sensor - PR Newswire UK

Roche Diabetes Care and Senseonics Announce Distribution Agreement for the Eversense® CGM System Introducing the First Implantable Long-term Glucose Sensor PR Newswire UK

Top Senseonics, Incorporated Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant